Everything
Second Dose of RTX May Aid RA Sufferers
Rheumatoid arthritis patients who failed to respond to initial treatment with rituximab (RTX) (a chimeric monoclonal antibody against the protein CD20) can still be successfully re-treated with a second course of RTX after six months.
Ovarian Cancer - Drug Pipeline Analysis and Market Forecasts to 2016
Ovarian Cancer - Drug Pipeline Analysis and Market Forecasts to 2016. Ovarian Cancer Market is Forecast to Show Significant Growth until 2016
treatment triple-negative breast cancer | Pharma Asia
A concerted R&D effort directed at triple-negative breast cancer patients promises new treatment options in the near future, according to research from independent market analyst, Datamonitor. Triple-negative breast cancer is characterised by high unmet need. While some triple-negative breast
Doctors hit out as Scots patients are denied new stomach cancer drug - Scotsman.com News
Doctors hit out as Scots patients are denied new stomach cancer drug - THE decision to deny patients with stomach cancer in Scotland access to a new drug to treat the disease has been criticised by medics and campaigners.
Safety of rituximab in rheumatoid arthritis: A long-term prospective single-center study of
Joint Bone Spine - Sous presse. Epreuves corrigées par l'auteur. Disponible en ligne depuis le mercredi 1 février 2012 - Safety of rituximab in rheumatoid arthritis: A long-term prospective single-center study of gammaglobulin concentrations and infections - EM|consulte
Cancer treatment controls macular edema related to diabetes and to cataract surgery | Science Blog
Science Blog: Treating DMME with bevacizumab (Avastin), an anti-vascular endothelial growth factor (anti-VEGF) medication that inhibits abnormal blood vessels, was studied in115 patients (139 eyes) by the Pan-American Collaborative Retina Study Group, led by J. Fernando Arevalo, MD, of the Caracas
Eye On Vision: December 2007
The leading source for trustworthy and timely health and medical news and information. Providing credible health information, supportive community, and educational services by blending award-winning expertise in content, community services, expert commentary, and medical review.
Beckman Coulter Completes Acquisition Of Diagnostics Business From Olympus - Pharmaceutical
Acquisition to add product depth and expand the geographic reach and scale for Beckman
WEEKLY VELCADE IN COMBINATION WITH RITUXIMAB IMPROVES PROGRESSION-FREE SURVIVAL AND RESPONSE RATE
Orlando, Fla., December 7, 2010 – today reported the final results of a Phase III study comparing VELCADE<sup>®</sup> (bortezomib) for Injection and rituximab to rituximab alone for the treatment of patients with relapsed or refractory follicular lymphoma (FL) who were rituximab-naïve or
Roche Warns of Counterfeit Avastin in the U S
The maker of the widely prescribed cancer drug Avastin is warning doctors and patients about counterfeit vials of the product that have been
Refine by Content Type:
- News and Blogs (628)
- News (589)
- Blogs (39)
- Press Releases (15)
- Resource (13)
- Forums (6)
Refine by Source:
- www.thelancet.com (294)
- download.thelancet.com (145)
- www.medpagetoday.com (84)
- seekingalpha.com (54)
- www.biospace.com (45)
- www.em-consulte.com (33)
- www.genengnews.com (21)
- www.aerzteblatt.de (20)
- www.imt.ie (12)
- biopharminternational.findpharma.com (11)
- blogs.webmd.com (11)
- www.prlog.org (9)
